Click Therapeutics Adds Randall Kaye, Austin Speier to C-Suite

Click Therapeutics has appointed Randall Kaye to serve as its chief medical officer. Kaye comes to Click from SSI Strategy, where he was chief scientific officer. New York-based Click also appointed Austin Speier to serve as chief strategy officer. Speier was previously vice president of emerging technologies at Precision for Medicine. Click is developing software that could be used to treat medical conditions such as depression, insomnia, acute coronary syndrome, and chronic pain. In July, Click raised $17 million in financing led by Sanofi Ventures.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times. View all posts by Frank Vinluan